• DRAMP ID

    • DRAMP39390
    • Peptide Name

    • Peptide 12
    • Source

    • Synthetic construct
    • Family

    • Flaviviridae
    • Gene

    • Not found
    • Sequence

    • DANFV
    • Sequence Length

    • 5
    • UniProt Entry

    • Protein Existence

    • Not found
    • SMILES

    • CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(N)=O)C(C)C
    • Biological Activity

    • [Ref.36739680]Peptides 12 at 200 μM exhibited cell protection effects below 50% against all four DENV serotypes(DENV-1, DENV-2, DENV-3, DENV-4); peptide 12 (200 μM) also showed inhibitions of all four
    • Target Organism

    • DENV
    • Hemolytic Activity

      • No hemolysis information or data found in the reference(s) presented in this entry
    • Cytotoxicity

      • Not found
    • Binding Target

    • plasma membrane
    • Linear/Cyclic

    • Linear
    • N-terminal Modification

    • Acetylation
    • C-terminal Modification

    • Amidation
    • Nonterminal Modifications and Unusual Amino Acids

    • Not found
    • Stereochemistry

    • L
    • Structure

    • Structure Description

    • PDB ID

    • Predicted Structure

    • There is no predicted structure for DRAMP39390.
    • Formula

    • C55H97N17O14
    • Absent Amino Acids

    • Cys,Asp,Glu,Phe,G
    • Common Amino Acids

    • Ala,Ile,L
    • Mass

    • 1220.46
    • PI

    • 11
    • Basic Residues

    • 3
    • Acidic Residues

    • 0
    • Hydrophobic Residues

    • 4
    • Net Charge

    • +2
    • Boman Index

    • 0
    • Hydrophobicity

    • -0.001
    • Aliphatic Index

    • 127
    • Half Life

      • Mammalian:1.9 hour
      • Yeast:>20 hour
      • E.coli:>10 hour
    • Extinction Coefficient Cystines

    • 1490
    • Absorbance 280nm

    • 1.22
    • Polar Residues

    • 3

DRAMP39390

  • ·Literature 1
    • Title

    • Development of novel antiviral peptides against dengue serotypes 1-4. 
    • Reference

    • Virology. 2023 Mar;580:10-27.
    • Author

    • Lee MF, Anasir MI, Poh CL.